Quest Diagnostics to Present Strategic Insights at J.P. Morgan Healthcare Conference 2026

Quest Diagnostics Prepares for Key Presentation at J.P. Morgan Healthcare Conference

Quest Diagnostics Incorporated, a leading provider of diagnostic information services, is set to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2026. The company’s Chairman and CEO, Jim Davis, alongside Executive Vice President and CFO, Sam Samad, will discuss the company’s strategic direction, recent performance metrics, and current trends in the healthcare market. This presentation, scheduled for 4:30 p.m. Pacific Time, will include a follow-up Q&A session, providing attendees with a comprehensive understanding of the company's initiatives and future outlook.

The J.P. Morgan Healthcare Conference is a significant event in the healthcare industry, attracting major stakeholders and investors. Quest Diagnostics aims to leverage this platform to communicate its mission of enhancing healthcare outcomes through diagnostic insights. With an extensive database of de-identified clinical lab results, the company serves approximately one in three adult Americans and collaborates with nearly half of the healthcare providers in the United States. This widespread engagement underscores Quest's substantial impact on the healthcare ecosystem and its commitment to delivering actionable health information.

Quest Diagnostics employs over 55,000 professionals who are dedicated to transforming lives through diagnostic services. The company’s strategic focus on data-driven insights positions it as a vital player in shaping the future of healthcare. By participating in the J.P. Morgan Healthcare Conference, Quest Diagnostics reinforces its role as a thought leader in the industry, as it seeks to inspire healthcare actions that lead to improved patient outcomes. The live webcast of the presentation will be available on the company’s investor relations website, ensuring that stakeholders can access this critical information.

In addition to its upcoming conference appearance, Quest Diagnostics continues to innovate in the realm of diagnostic solutions. The company is committed to expanding its services and enhancing its capabilities to meet the evolving needs of patients and healthcare providers. This dedication to continuous improvement aligns with its vision of contributing to a healthier world through informed health decisions.

As Quest Diagnostics prepares for its presentation, it remains focused on its mission to provide essential diagnostic insights that empower individuals and healthcare organizations alike. Stakeholders are encouraged to stay engaged with the company’s developments and explore its comprehensive resources available on their website.